Drug information provided by: Merative, Micromedex®
Asfotase alfa injection is used to treat patients with perinatal, infantile, and juvenile-onset hypophosphatasia (HPP). Hypophosphatasia is a genetic condition that weakens and softens the bones, causing abnormal development of the bones and teeth.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!